Search
Givastomig
go.drugbank.com/drugs/DB18618InvestigationalGivastomig is an anti-Claudin 18.2 and 4.1BB bispecific antibody.
Synonyms: an anti-Claudin 18.2 and 4.1BB Bispecific AntibodyDoxofylline
go.drugbank.com/drugs/DB09273InvestigationalDoxofylline is a methylxanthine derivative with the presence of a dioxolane group in position 7. … As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies.
Categories: Adrenergic beta-2 Receptor AgonistsMianserin
go.drugbank.com/drugs/DB06148ApprovedWithdrawnMianserin was previously available internationally, however in most markets it has been phased out in favour of [mirtazapine].
Categories: Serotonin Receptor Antagonists, Dopamine D2 Receptor AntagonistsTildacerfont
go.drugbank.com/drugs/DB18545InvestigationalTildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring
ARCT-810
go.drugbank.com/drugs/DB17683InvestigationalARCT-810 is an mRNA replacement therapy that delivers ornithine transcarbamylase mRNA to hepatocytes.
AMT-162
go.drugbank.com/drugs/DB17922InvestigationalAMT-162 is an adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA.
Amfenac
go.drugbank.com/drugs/DB15911InvestigationalAmfenac is an arylacetic acid derivative and a non0steroidal anti-inflammatory agent.[A275203, A275208]
JB991
go.drugbank.com/drugs/DB05081ExperimentalIn addition a closely related cyclopentenone prostaglandin analogue has been shown to exert marked anti-inflammatory effect in vivo in an animal model. The drug will be applied topically on the skin. … The drug exerts marked antiproliferative and pro-apoptotic effect in human keratinocytes and fibroblasts in vitro.
Zilovertamab vedotin
go.drugbank.com/drugs/DB18457InvestigationalZilovertamab vedotin is an Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (
Gaboxadol
go.drugbank.com/drugs/DB06554InvestigationalGaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck, who reported increased deep sleep without the reinforcing … Development of Gaboxadol was stopped in March 2007 after concerns regarding safety and efficacy. It acts on the GABA system, but in a seemingly different way from benzodiazepines and other sedatives.